---
title: "Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263996571.md"
description: "Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection"
datetime: "2025-11-03T11:00:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263996571.md)
  - [en](https://longbridge.com/en/news/263996571.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263996571.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263996571.md) | [English](https://longbridge.com/en/news/263996571.md)


# Apeloa Pharmaceutical Obtains Drug Registration for Levocarnitine Injection



### 相關股票

- [APELOA (000739.CN)](https://longbridge.com/zh-HK/quote/000739.CN.md)

## 相關資訊與研究

- [Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotics](https://longbridge.com/zh-HK/news/268186949.md)
- [Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025](https://longbridge.com/zh-HK/news/262086974.md)
- [Hengrui Pharmaceuticals Gets Nod to Trial SHR-9803 for Injection](https://longbridge.com/zh-HK/news/278830096.md)
- [Cipla says U.S. unit to initiate recall of lanreotide injection](https://longbridge.com/zh-HK/news/278444171.md)
- [Changchun High-Tech Industry Files Clinical Trial Application for GenSci161 Injection](https://longbridge.com/zh-HK/news/277574518.md)